Skip to content
← Back to this collection

PUBLICATIONS · 11268452

Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Anticancer Res
Publication date
2000 Sep-Oct
First author
Hartmann JT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hartmann JT
      type
      Author
    2. name
      Fels LM
      type
      Author
    3. name
      Franzke A
      type
      Author
    4. name
      Knop S
      type
      Author
    5. name
      Renn M
      type
      Author
    6. name
      Maess B
      type
      Author
    7. name
      Panagiotou P
      type
      Author
    8. name
      Lampe H
      type
      Author
    9. name
      Kanz L
      type
      Author
    10. name
      Stolte H
      type
      Author
    11. name
      Bokemeyer C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hartmann JT
      type
      Author
    2. name
      Fels LM
      type
      Author
    3. name
      Franzke A
      type
      Author
    4. name
      Knop S
      type
      Author
    5. name
      Renn M
      type
      Author
    6. name
      Maess B
      type
      Author
    7. name
      Panagiotou P
      type
      Author
    8. name
      Lampe H
      type
      Author
    9. name
      Kanz L
      type
      Author
    10. name
      Stolte H
      type
      Author
    11. name
      Bokemeyer C
      type
      Author
    bibliography ids
    1. nci-bib-e66aa96bdb616674c7c3940e
    book metadata
    content sha256
    20f51e8fa0a4e26079282625f427c89e64983bc5d349180409a43febabbbdef5
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:11268452
      immutable id
      pubmed:11268452@20f51e8fa0a4e26079282625f427c89e64983bc5d349180409a43febabbbdef5
      journal
      abbreviation
      Anticancer Res
      issn electronic
      Source null
      issn print
      0250-7005
      issue
      5C
      name
      Anticancer research
      nlm unique id
      8102988
      pages
      3767-73
      volume
      20
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        11268452
        provenance
        batch id
        30d2cd7affbbb92b6784
        provider
        NCBI PubMed ESummary
        record sha256
        333e6c9a18ff9b702affba9ba5597ef17096e50cc3273a46e015b40335af1935
        response sha256
        ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
        retrieved at
        2026-09-09T23:45:39.779418+00:00
        publication date
        display
        2000 Sep-Oct
        precision
        range_or_season
        year
        2000
        publication types
        1. Clinical Trial
        2. Comparative Study
        3. Controlled Clinical Trial
        4. Journal Article
        5. Multicenter Study
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/11268452/
        title
        Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.

        Preserved source evidence · Not medical advice